Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity

Author(s):  Biundo Bruce, Gogola Margaret

Issue:  Jul/Aug 2015 - Volume 19, Number 4
View All Articles in Issue

Page(s):  289-293

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 1
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 2
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 3
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 4
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 5

Download in electronic PDF format for $75

Abstract:  Estrogen therapy is a well-known and commonly used symptomatic treatment of hot flashes, night sweats and vaginal dryness associated with menopause. The most active estrogen, estradiol, is also understood to have a protective effect against osteoporosis. Like many hormones, though, estradiol has many roles in the body, both in males and females, and studies of these roles continue to emerge. A major function of estradiol involves obesity, insulin resistance, and cardiovascular disease; studies have shown the beneficial effects of estradiol in these areas, and this is somewhat at variance with traditional belief. In recent years, many researchers have studied its protective, beneficial effect, and have arrived at convincing evidence. In females, and, to some extent in males, estradiol is very important in protecting against obesity and lessening the likelihood of insulin resistance and cardiovascular disease. For both menopausal women and hypogonadal men, estradiol levels should be monitored and considered for long-term healthcare benefits.

Related Keywords: Bruce Biundo, RPh, FACA, Margaret Gogola, PharmD, menopausal women, hypogonadal men, estrogen replacement therapy, estradiol, menopause, osteoprotection, osteoporosis, obesity, insulin resistance, diabetes, cardiovascular disease, visceral adipose tissue, aromatase, sex hormones, estrogen receptors, weight gain, fatty acid oxidation, adipocytokines, insulin sensitivity

Related Categories: DIABETES, HRT, CARDIOLOGY, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce
, Gogola Margaret
Jul/Aug 2015
Pg. 289-293

Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

Andropause: New Perspectives
Biundo Bruce
May/Jun 2004
Pg. 175-178

Emerging Evidence for Androgen Replacement Therapy in Aging Men
Bramwell Bethany L
Mar/Apr 2010
Pg. 94-99

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
May/Jun 2018
Pg. 190-195

Women's Health Book Reviews
Reed-Kane Dana
Sep/Oct 1999
Pg. 357-359

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
Jan/Feb 2024
Pg. 22-27

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Gillson George R
, Zava David T
Sep/Oct 2003
Pg. 330-338

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris
, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010
Pg. 165-170

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Healthful Living: Good Practices for Good Health
Jackson Kathy
May/Jun 2002
Pg. 164-166

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
Mar/Apr 2002
Pg. 142-146

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
Jan/Feb 2004
Pg. 16-21

Return to Top